AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® Subcutaneous Induction in Patients with Crohn's Disease Pharmaceutical Investing
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia Life Science Investing
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® Oral Solution Life Science Investing
Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa Life Science Investing
NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference Life Science Investing
NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update Life Science Investing
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2025 on Thursday, March 12, 2026, After Close of U.S.-Based Financial Markets Life Science Investing
Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin Development Program for Treatment of Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis and Portal Hypertension, on March 10, 2026 at 12:00 PM ET Life Science Investing
Entera Bio to Participate in the Leerink Partners 2026 Global Healthcare Conference Life Science Investing
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer Life Science Investing
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress Life Science Investing
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart maintains high levels of viral suppression in long-acting HIV treatment regimen Pharmaceutical Investing
